"强化企业在科技创新中的主体地位，推动创新资源向企业集聚……"日前发布的《中共中央关于制定国 民经济和社会发展第十五个五年规划的建议》（以下简称《建议》），再次突出了企业在创新中的关键 角色，引人关注。 在四川遂宁，科创企业正享受研发费用加计扣除带来的税惠红利；在浙江杭州科技城，园区推出科技成 果转化费用损失保险，为企业创新保驾护航……《建议》发布两个月来，相关要求正在各地加快落地， 一系列"政策礼包"纷至沓来。 习近平总书记对企业创新主体地位高度重视。2020年7月，他在企业家座谈会上强调，企业家要做创新 发展的探索者、组织者、引领者，勇于推动生产组织创新、技术创新、市场创新，重视技术研发和人力 资本投入，有效调动员工创造力，努力把企业打造成为强大的创新主体。 不断强化的战略导向，也让企业家们增强了发展的信心。在调研采访中，多位企业负责人向科技日报记 者表达了同样的感受。可以预见，"十五五"时期，企业将进一步从技术创新的执行者，转变为国家创新 体系的策源者与组织者。未来，无论是关键技术突破，还是新兴赛道开拓，企业都将牢牢站稳舞台"C 位"。 强化再强化，宏观政策一脉相承 从整体看，2024年全社会研发经费投 ...

国仪量子产品成功打破国外垄断。在营收高速增长下，公司启动科创板上市，助力高端科学仪器国产化。 高端科学仪器是前沿科技、国家安全和工业研发的基石，其高端化水平代表了整个国家的创新能力和科学技术发展水平，量子精密测量与量子计算更是国 家重点鼓励和支持的前沿技术行业。近年来，国家鼓励高端科学仪器行业的国产化和技术攻关，支持量子科技的研发与应用，陆续出台了多项政策，而在 国家政策鼓励下，除了相关已上市企业在二级市场受到资金热捧外，行业内一些未上市企业也加快了上市步伐，比如国仪量子技术（合肥）股份有限公司 （以下简称"国仪量子"） 就计划于2025年12月启动IPO，上市目标指向上交所科创板。 国仪量子表示，通过本次上市和募投项目的实施，公司将进一步提升公司治理水平，并结合股权激励完善核心人员激励及约束机制，持续吸纳引进复合背 景的专业人士，充实技术研发队伍储备，这将成为公司持续激发创新动力、实现高速增长和高质量发展的源动力，以回馈社会和广大投资者。 中科大少年班走出的领军人 国仪量子的实际控制人为贺羽和荣星。 他们并不直接持有公司股份，但通过合肥司坤间接控制公司27.20%表决权，同时贺羽还通过合肥微扰间接控制公 司 ...

"十五五"规划将量子科技纳入未来产业版图，与生物制造、脑机接口、具身智能等一同被赋予"新经济增长点"的战略 使命。政策东风之下，量子科技领域的IPO热潮已悄然拉开序幕。 自成立以来，公司相继推出电子顺磁共振波谱仪、扫描NV探针显微镜、场发射扫描电子显微镜、聚焦离子束电子束 双束显微镜等系列产品，打破了国际巨头在国内仪器市场部分细分领域的长期垄断或主导局面。 格隆汇获悉，近日，国仪量子技术（合肥）股份有限公司（简称"国仪量子"）向上交所递交招股书申报稿，拟在科创 板上市，保荐人为华泰联合证券有限责任公司。 国仪量子专注于高端科学仪器的研发，面向量子科技、材料科学、化学化工、生物医药、先进制造等多个领域，向高 校及科研院所、企业提供科技前沿探索所需的高端科学仪器装备、以增强型量子传感器为代表的核心关键器件及解决 方案。 这家公司质地如何？今天就来一探究竟。 01 聚焦高端科学仪器领域，客户较为分散 国仪量子聚焦高端科学仪器的研发，其仪器产品主要属于实验分析仪器的范畴，实验分析仪器是科学仪器的重要分 支，主要用于实验室环境中的样品检测和分析。 国仪量子形成了量子信息技术与自旋共振、电子显微镜、随钻测量、气体吸附分析 ...

2025年12月10日，上交所官网披露信息显示，国仪量子技术（合肥）股份有限公司（下称"国仪量子"）IPO申请正式获受理，保荐机构为华泰联合证券， 容诚会计师事务所（特殊普通合伙）、安徽天禾律师事务所分别承担审计及法律服务。 2025年12月19日，国仪量子IPO审核状态更新为"已问询"，计划募资11.69亿元，冲击科创板，剑指"国产量子传感器第一股"。 作为国内传感器赛道稀缺的独角兽企业，国仪量子依托中国科学技术大学的硬核技术积淀，在量子传感、自旋共振等高端科学仪器赛道实现多项技术突 破，打破了海外厂商的长期垄断格局。其核心产品电子顺磁共振波谱仪已走向全球，构建了覆盖核心关键器件、科学仪器装备及行业解决方案的完整产品 服务体系。 公司主打以增强型量子传感器为代表的核心器件，配套提供扫描NV探针显微镜等分析测试类高端科学仪器，业务已渗透材料科学、生物医学、工业质 检、能源勘探等多个领域。产品切入宁德时代、比亚迪、京东方等头部企业供应链，客户遍布国内外超80所985/211高校及150余家科研院所。 截至招股书签署日，国仪量子的股权结构呈现显著分散特征。公司实际控制人为贺羽与荣星，二人自2017年7月起签署一致 ...

Financing Overview - A total of 99 financing events occurred in the tech industry from December 6 to December 12, 2025, with 81 events in China and 18 abroad[9] - The leading sectors in domestic financing were advanced manufacturing (44 events), artificial intelligence (23 events), and automotive transportation (5 events)[9] IPO and Prospectus Submissions - Wisdom Tree was listed on the Hong Kong Stock Exchange on December 8, 2025[12] - Fast Innovation submitted a prospectus for a proposed listing on the Hong Kong main board[14] - National Instrument Quantum and Precision Laser submitted prospectuses for listings on the Shanghai STAR Market[16][19] Market Performance - The Shanghai Composite Index fell by 0.34% to 3889 points, while the Shenzhen Component Index rose by 0.84% to 13258 points, and the ChiNext Index increased by 2.74% to 3194 points[21] - The semiconductor index rose by 2.84%, automotive electronics by 1.82%, artificial intelligence by 0.45%, and the metaverse index by 1.58%[21] Valuation Metrics - The PE ratios for the semiconductor, automotive electronics, artificial intelligence, and metaverse indices were 130.50, 37.94, 72.67, and 51.63, respectively, reflecting week-on-week increases of 2.5%, 1.5%, 0.8%, and 1.7%[25] - The PB ratios for the same indices were 6.34, 3.87, 7.51, and 5.56, with week-on-week increases of 2.5%, 1.4%, 0.9%, and 1.7%[27] Risk Factors - Market competition risk exists due to rapid growth in key sectors like semiconductors and AI, potentially intensifying competition[28] - Risks related to technological advancements not meeting expectations could hinder sector growth[29] - Market demand growth may fall short of expectations, impacting overall sector development[30]

合肥 "量子大道"上即将冲出第二个 IPO 。 这位 90 后中科大校友联合创立的国仪量子技术（合肥）股份有限公司（以下简称：国仪量子），日 前在上交所科创板 IPO 获受理，拟募资 11.69 亿元。 「IPO全观察」 栏目聚焦首次公开募股公司，报道企业家创业经历与成功故事，剖析公司商业模式 和经营业绩，并揭秘VC、CVC等各方资本力量对公司的投资加持。 作者丨巴里 编辑丨 关雎 图源丨摄图网 其背后，高瓴创投、 IDG 资本、科大讯飞等明星资本云集，公司估值已超过 10 亿美元，成为名副 其实的独角兽。 至此，它与比邻而居的国盾量子、本源量子，共同构成了中国量子科技的 "三剑客"，正以自主可控 的硬核技术，在全球量子科技竞争中展开集体冲锋。 国仪量子董事长贺羽，图源：合肥市广播电视台 几乎在同一时期，另一位青年 ——荣星，正在量子科研的道路上历经锤炼。 比贺羽年长近十岁的荣星，于 2001 年考入中国科学技术大学物理学院。 2005 年，读研一的他选择 科学仪器作为研究方向，开始了与量子的无限"纠缠"。 然而，等待他的是前所未有的挑战： "仪器功能受限、方案被反复推翻、实验结果不及预期……"在 当时国内该 ...

Core Viewpoint - Guoyi Quantum's IPO application has been accepted, aiming to raise 1.169 billion yuan for projects focused on high-end scientific instrument industrialization, quantum technology research institute construction, and application center network development, all centered around its main business in scientific instruments [1][2]. Group 1: Company Mission and Product Offerings - Guoyi Quantum is committed to the mission of "creating instruments for the country," focusing on the independent research and industrialization of high-end scientific instruments [5]. - The company's product range includes electronic paramagnetic resonance spectrometers, scanning NV probe microscopes, field emission scanning electron microscopes (SEM), and focused ion beam electron beam dual beam microscopes (FIB-SEM), breaking the monopoly of international instrument giants in several niche areas [5]. - The electronic microscope series has become a significant revenue driver, with projected sales revenue of 246 million yuan in 2024, accounting for 50.80% of total revenue, indicating that domestic electron microscopes can compete with international brands [5]. Group 2: Financial Performance and Growth - The company has experienced rapid revenue growth, with figures rising from 151 million yuan in 2022 to 399 million yuan in 2023, and projected to reach 501 million yuan in 2024, resulting in a compound annual growth rate of 81.94% over the past three years [8]. - Despite the revenue growth, the company has not yet achieved profitability due to ongoing high levels of R&D and market investment, with R&D expenses accounting for 75.34% of revenue in 2022 and 23.13% in 2024 [8]. - As of the end of 2024, the company will have a research and development staff ratio of 31.28% and has been granted 129 authorized invention patents, contributing to the establishment of national standards in the field of quantum measurement [8]. Group 3: Fundraising and Strategic Focus - The IPO funds will be allocated to three main projects: - High-end scientific instrument industrialization project to expand existing product capacity and promote new product launches, solidifying its industrial advantages in electron microscopes and quantum measurement [9]. - Quantum technology development research institute construction project to enhance cutting-edge technology research in quantum sensing and precision measurement, maintaining technological leadership [9]. - Application center network construction project to establish domestic and international demonstration, testing, and service centers, improving customer support capabilities and brand influence, and accelerating global market expansion [9]. Group 4: Market Position and Future Outlook - In a global scientific instrument market dominated by international giants like Thermo Fisher, Danaher, and Ametek, Guoyi Quantum is gradually making inroads in strategic areas such as electron microscopy and quantum precision measurement through independent innovation [11]. - Successfully listing on the Sci-Tech Innovation Board will provide strong support for subsequent R&D expansion and market development, injecting new momentum into China's path toward self-sufficiency in high-end scientific instruments [11].

本次募集资金投资项目经 2025 年第三次临时股东会确定，由董事会负责实施，主要用于投资如下项 目： | | | 智通财经APP获悉，12月10日，国仪量子技术（合肥）股份有限公司(简称：国仪量子)上交所科创板 IPO已受理。华泰联合证券为保荐机构，拟募资11.69亿元。 招股书显示，国仪量子自成立以来专注于高端科学仪器的研发，面向量子科技、材料科学、化学化工、 生物医药、先进制造等多个领域，向全球范围内的高校及科研院所、企业提供科技前沿探索所需的高端 科学仪器装备、以增强型量子传感器为代表的核心关键器件以及解决方案，积极为解决"卡脖子"问题贡 献力量。 从全球范围来看，科学仪器市场呈现高度集中化趋势，欧美企业凭借技术积累和品牌优势占据主导地 位，尤其是在高精度、高复杂度的高端仪器领域，国际巨头几乎呈垄断态势。随着国家对科技创新和高 端制造的高度重视，以及下游生物医药、半导体、新材料等产业的快速发展，国内高端科学仪器需求持 续增长，但国产化率仍然较低，进口依赖度较高，国产企业正通过技术突破和产品升级逐步缩小与国际 巨头的差距。 国仪量子自成立以来积极参与国内乃至国际市场竞争，推出的电子顺磁共振波谱仪、扫描 N ...

Core Insights - Zhejiang University has announced procurement intentions for 49 items of laboratory equipment, with a total budget of 105 million yuan [1][2][5] - The procurement includes advanced instruments such as high-power liquid cooling machines, femtosecond lasers, and various types of spectrometers, expected to be purchased between August and October 2025 [2][3][4] Procurement Overview - The total budget for the procurement is 105 million yuan, covering 49 items of equipment [1][2] - Key items include: - Field Emission High-resolution Transmission Electron Microscope (FE-TEM) [3] - Electron Paramagnetic Resonance Spectrometer (EPR) [3] - Microbial Identification Mass Spectrometer [4] - The expected procurement timeline is from August to October 2025 [2] Equipment Specifications - **Field Emission High-resolution Transmission Electron Microscope**: Capable of sub-nanometer resolution, used in materials science and biomedical research [3] - **Electron Paramagnetic Resonance Spectrometer**: The only instrument that can directly detect unpaired electrons, crucial for material science and chemistry [3] - **Microbial Identification Mass Spectrometer**: A rapid and accurate method for microbial identification, essential in clinical microbiology and food safety [4] Related Procurement Activities - Previous procurement activities by Zhejiang University include budgets of 1.22 billion yuan and 230 million yuan for various laboratory instruments [5][6] - The university has consistently invested in upgrading its research capabilities through significant equipment purchases [5][6]

Core Insights - Yunnan University Bio-X Center has allocated 17.36 million yuan for the update of major educational equipment, with seven instrument companies winning bids [2][4]. Summary by Sections Project Overview - The Yunnan University Bio-X Center focuses on interdisciplinary research in biomedical and biopharmaceutical fields, integrating resources from life sciences, medicine, and pharmacy to enhance the synergy between basic research and industrial applications [4]. Bid Results - The procurement results for the major equipment update include four domestic instrument companies and three foreign companies: Dapu Biology, Zircon Photonics, Xiaocroc Biology, Guoyi Quantum, SCIEX, Agilent, and Revvity [3][4]. Domestic Equipment Procurement - The first segment of the domestic equipment procurement was awarded to Yunnan Express Technology Co., Ltd. for 4.66 million yuan, with a total score of 97.51 [5][6]. - The second segment was awarded to Yunnan Yunrui Technology Co., Ltd. for 6.77 million yuan, with a total score of 95.71 [6]. Equipment Details - Key equipment includes: - Flow Cytometer from Dapu Biology, priced at 3,049,300 yuan [6]. - Rapid Ultra-High Resolution Live Cell Imaging System from Zircon Photonics, priced at 2,398,000 yuan [6]. - Molecular Interaction Analysis System from Xiaocroc Biotechnology, priced at 2,999,000 yuan [6]. Imported Equipment Procurement - The first segment of the imported equipment procurement was awarded to Guangdong Keke Instrument Equipment Co., Ltd. for 14.35 million yuan, with a total score of 97.46 [7][8]. - The second segment was awarded to Guoyi Quantum Technology (Hefei) Co., Ltd. for 1.95 million yuan, with a total score of 98.43 [8]. Imported Equipment Details - Key imported equipment includes: - Liquid Chromatography-Mass Spectrometry System from SCIEX, priced at 2,799,000 yuan [8]. - Multi-Mode Imaging System from Agilent, priced at 1,499,000 yuan [8]. - Super-Resolution Live Animal Deep Imaging System from Revvity, priced at 3,999,000 yuan [8]. - Electron Paramagnetic Resonance Spectrometer from Guoyi Quantum, priced at 1,950,000 yuan [8].